634.7500 -15.15 (-2.33%)
NSE May 02, 2025 15:31 PM
Volume: 331.5K
 

634.75
-2.33%
Geojit BNP Paribas
Strides reported its Q2FY22 revenue at Rs. 721cr, (4.8% QoQ, -9% YoY), enabled by a bounce back in the other regulated markets which was partially offset by an underperformance in the US markets. US markets (34% of total revenues) witnessed a 17% QoQ/-38% YoY...
Strides Pharma Science Ltd.'s price crossed below 50Day SMA today
More from Strides Pharma Science Ltd.
Recommended